|
Volumn 95, Issue 16, 1998, Pages 9064-9066
|
Antiangiogenic gene therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOGENIC FACTOR;
ANGIOSTATIN;
FUMAGILLOL CHLOROACETYLCARBAMATE;
PROTEIN P53;
THROMBOSPONDIN 1;
VASCULOTROPIN;
CANCER INHIBITION;
CLINICAL TRIAL;
GENE THERAPY;
GENE TRANSFER;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS INHIBITION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
TUMOR SUPPRESSOR GENE;
TUMOR VASCULARIZATION;
ANIMALS;
GENE THERAPY;
MICE;
NEOVASCULARIZATION, PATHOLOGIC;
|
EID: 0032482939
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.95.16.9064 Document Type: Note |
Times cited : (201)
|
References (34)
|